Skip to content

The Efficacy of Intensive Nutritional Supplement in Patient With Stroke

The Efficacy of Intensive Nutritional Supplement in Patient With Stroke: a Prospective Randomized Controlled Trial

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01810263
Enrollment
34
Registered
2013-03-13
Start date
2012-05-31
Completion date
2014-07-31
Last updated
2015-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Malnutrition

Keywords

stroke, malnutrition, high protein

Brief summary

The aim of this prospective randomized controlled study is to demonstrate the efficacy of Intensive Nutritional Supplement in Patient with Stroke.

Detailed description

Elderly patients, including those who have had a stroke, are more at risk of undernutrition than other groups because of reduced nutritional reserves, prolonged hospital stay and increased demands of repeated ill-health. Stroke may compound these problems because of physical and mental incapacity, problems with perception and communication, and swallowing disorders. The full extent of undernutrition and its independent contribution to stroke outcome is not presently known. It is also not known whether it can be corrected, and whether doing so would improve the outcome. The aim of this study is therefore to describe the efficacy of Intensive Nutritional Supplement in Patient with Stroke.

Interventions

DIETARY_SUPPLEMENThigh protein supplement

Dietary Supplement: high protein supplement

Sponsors

Myongji Hospital
CollaboratorOTHER
Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 1 st onset stroke patient * MRI confirms his/her stroke * more than 2.5% weight los within 2 weeks * initial serum albumin \< 35 g/l * BMI \< 18.5 * more than MMSE 10 * medically stable

Exclusion criteria

* recurrent stroke patient * malabsorption patient * terminal cancer

Design outcomes

Primary

MeasureTime frameDescription
Modified Barthel Index (MBI) Score at 6 Months6 monthsScale range: 0-100 (higher values represent a better outcome)

Secondary

MeasureTime frame
Chemical Laboratory Findings6 months

Other

MeasureTime frame
Body Mass Index6 months
Triceps Skin Fold Thickness6 months
Subjective Global Assessment6 months

Countries

South Korea

Participant flow

Recruitment details

* first ever stroke * MRI confirms his/her stroke * weight loss over 2.5% within 2 weeks after the stroke onset * MMSE \>= 10 * medically stable

Participants by arm

ArmCount
High Protein Supplement
high protein supplement given
16
Control
no intervention
18
Total34

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up87

Baseline characteristics

CharacteristicHigh Protein SupplementControlTotal
Age, Continuous62.8 years
STANDARD_DEVIATION 16
65.8 years
STANDARD_DEVIATION 14.3
64.4 years
STANDARD_DEVIATION 15.2
Region of Enrollment
Korea, Republic of
16 participants18 participants34 participants
Sex: Female, Male
Female
9 Participants7 Participants16 Participants
Sex: Female, Male
Male
7 Participants11 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 18
serious
Total, serious adverse events
0 / 160 / 18

Outcome results

Primary

Modified Barthel Index (MBI) Score at 6 Months

Scale range: 0-100 (higher values represent a better outcome)

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
High Protein SupplementModified Barthel Index (MBI) Score at 6 Months23.3 units on a scaleStandard Deviation 2.7
ControlModified Barthel Index (MBI) Score at 6 Months21.9 units on a scaleStandard Deviation 2.7
Secondary

Chemical Laboratory Findings

Time frame: 6 months

Other Pre-specified

Body Mass Index

Time frame: 6 months

Other Pre-specified

Subjective Global Assessment

Time frame: 6 months

Other Pre-specified

Triceps Skin Fold Thickness

Time frame: 6 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026